10-Q 1 a08-1538_110q.htm 10-Q

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

For the quarterly period ended December 1, 2007

 

Commission File Number 0-20214

 

BED BATH & BEYOND INC.

(Exact name of registrant as specified in its charter)

 

New York

 

11-2250488

(State of incorporation)

 

(IRS Employer Identification No.)

 

 

 

650 Liberty Avenue, Union, New Jersey    07083

(Address of principal executive offices)    (Zip Code)

 

Registrant’s telephone number, including area code:  908/688-0888

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  x      No  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  x

Accelerated filer  o

Non-accelerated filer  o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes  o      No  x

 

Number of shares outstanding of the issuer’s Common Stock:

 

Class

 

Outstanding at December 1, 2007

Common Stock - $0.01 par value

 

261,952,704

 

 



 

BED BATH & BEYOND INC. AND SUBSIDIARIES

 

INDEX

 

 

 

 

 

PART I - FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements (unaudited)

 

 

 

 

 

 

Consolidated Balance Sheets
December 1, 2007 and March 3, 2007

 

 

 

 

 

 

Consolidated Statements of Earnings
Three Months and Nine Months Ended December 1, 2007 and November 25, 2006

 

 

 

 

 

 

Consolidated Statements of Cash Flows
Nine Months Ended December 1, 2007 and November 25, 2006

 

 

 

 

 

 

Notes to Consolidated Financial Statements

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

 

PART II - OTHER INFORMATION

 

 

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

 

 

Item 1A.

Risk Factors

 

 

 

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

 

 

Item 6.

Exhibits

 

 

 

 

 

 

Signatures

 

 

 

 

 

 

Exhibit Index

 

 

 

 

 

 

Certifications

 

 

2



 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Consolidated Balance Sheets

(in thousands, except per share data)

(unaudited)

 

 

 

December 1,

 

March 3,

 

 

 

2007

 

2007

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

190,433

 

$

213,381

 

Short term investment securities

 

186,797

 

774,881

 

Merchandise inventories

 

1,797,784

 

1,505,800

 

Other current assets

 

314,800

 

204,552

 

 

 

 

 

 

 

Total current assets

 

2,489,814

 

2,698,614

 

 

 

 

 

 

 

Long term investment securities

 

128

 

102,692

 

Property and equipment, net

 

1,064,081

 

929,507

 

Other assets

 

309,869

 

228,491

 

 

 

 

 

 

 

Total assets

 

$

3,863,892

 

$

3,959,304

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

680,716

 

$

615,156

 

Accrued expenses and other current liabilities

 

263,231

 

245,267

 

Merchandise credit and gift card liabilities

 

156,789

 

143,737

 

Current income taxes payable

 

15,668

 

140,913

 

 

 

 

 

 

 

Total current liabilities

 

1,116,404

 

1,145,073

 

 

 

 

 

 

 

Deferred rent and other liabilities

 

187,588

 

165,080

 

Income taxes payable

 

86,365

 

 

 

 

 

 

 

 

Total liabilities

 

1,390,357

 

1,310,153

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Preferred stock - $0.01 par value; authorized - 1,000 shares; no shares issued or outstanding

 

 

 

 

 

 

 

 

 

Common stock - $0.01 par value; authorized - 900,000 shares; issued 311,667 and 309,750 shares, respectively; outstanding 261,953 and 277,074 shares, respectively

 

3,117

 

3,098

 

Additional paid-in capital

 

790,598

 

737,209

 

Retained earnings

 

3,556,845

 

3,153,856

 

Treasury stock, at cost; 49,714 and 32,676 shares, respectively

 

(1,881,092

)

(1,249,397

)

Accumulated other comprehensive income

 

4,067

 

4,385

 

 

 

 

 

 

 

Total shareholders’ equity

 

2,473,535

 

2,649,151

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

 

$

3,863,892

 

$

3,959,304

 

 

See accompanying Notes to Consolidated Financial Statements.

 

3



 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Consolidated Statements of Earnings

(in thousands, except per share data)

(unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

December 1,

 

November 25,

 

December 1,

 

November 25,

 

 

 

2007

 

2006

 

2007

 

2006

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

1,794,747

 

$

1,619,240

 

$

5,115,756

 

$

4,622,442

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

1,046,881

 

915,167

 

2,989,623

 

2,650,022

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

747,866

 

704,073

 

2,126,133

 

1,972,420

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

544,714

 

492,939

 

1,547,553

 

1,392,914

 

 

 

 

 

 

 

 

 

 

 

Operating profit

 

203,152

 

211,134

 

578,580

 

579,506

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

4,968

 

10,643

 

21,575

 

30,230

 

 

 

 

 

 

 

 

 

 

 

Earnings before provision for income taxes

 

208,120

 

221,777

 

600,155

 

609,736

 

 

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

69,888

 

79,341

 

210,268

 

221,334

 

 

 

 

 

 

 

 

 

 

 

Net earnings

 

$

138,232

 

$

142,436

 

$

389,887

 

$

388,402

 

 

 

 

 

 

 

 

 

 

 

Net earnings per share - Basic

 

$

0.53

 

$

0.51

 

$

1.46

 

$

1.38

 

Net earnings per share - Diluted

 

$

0.52

 

$

0.50

 

$

1.44

 

$

1.36

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding - Basic

 

261,588

 

281,097

 

267,074

 

280,629

 

Weighted average shares outstanding - Diluted

 

265,006

 

285,664

 

270,929

 

285,112

 

 

See accompanying Notes to Consolidated Financial Statements.

 

4



 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

(in thousands, unaudited)

 

 

 

Nine Months Ended

 

 

 

December 1,

 

November 25,

 

 

 

2007

 

2006

 

Cash Flows from Operating Activities:

 

 

 

 

 

Net earnings

 

$

389,887

 

$

388,402

 

Adjustments to reconcile net earnings to net cash provided by operating activities:

 

 

 

 

 

Depreciation

 

116,284

 

95,634

 

Amortization of bond premium

 

1,446

 

2,774

 

Stock-based compensation

 

31,233

 

43,085

 

Excess tax benefit from stock-based compensation

 

1,363

 

3,773

 

Deferred income taxes

 

(6,936

)

(28,664

)

(Increase) decrease in assets, net of effect of acquisition:

 

 

 

 

 

Merchandise inventories

 

(277,476

)

(337,635

)

Trading investment securities

 

(2,705

)

(2,295

)

Other current assets

 

(85,067

)

(80,251

)

Other assets

 

435

 

(323

)

Increase (decrease) in liabilities, net of effect of acquisition:

 

 

 

 

 

Accounts payable

 

76,197

 

135,506

 

Accrued expenses and other current liabilities

 

26,301

 

19,976

 

Merchandise credit and gift card liabilities

 

9,512

 

11,871

 

Income taxes payable

 

(61,384

)

(56,142

)

Deferred rent and other liabilities

 

20,847

 

22,004

 

 

 

 

 

 

 

Net cash provided by operating activities

 

239,937

 

217,715

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

 

 

 

 

 

 

Purchase of held-to-maturity investment securities

 

 

(124,125

)

Redemption of held-to-maturity investment securities

 

366,232

 

212,586

 

Purchase of available-for-sale investment securities

 

(841,805

)

(824,830

)

Redemption of available-for-sale investment securities

 

1,167,480

 

783,815

 

Capital expenditures

 

(257,054

)

(235,187

)

Payment for acquisition, net of cash acquired

 

(85,893

)

 

 

 

 

 

 

 

Net cash provided by (used in) investing activities

 

348,960

 

(187,741

)

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of stock options

 

15,741

 

23,701

 

Excess tax benefit from stock-based compensation

 

4,109

 

6,607

 

Repurchase of common stock, including fees

 

(631,695

)

(988

)

Payment of deferred purchase price for acquisition

 

 

(6,667

)

 

 

 

 

 

 

Net cash (used in) provided by financing activities

 

(611,845

)

22,653

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

(22,948

)

52,627

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

Beginning of period

 

213,381

 

247,697

 

End of period

 

$

190,433

 

$

300,324

 

 

See accompanying Notes to Consolidated Financial Statements.

 

5



 

BED BATH & BEYOND INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

(unaudited)

 

1) Basis of Presentation

 

The accompanying consolidated financial statements have been prepared without audit. In the opinion of management, the accompanying consolidated financial statements contain all adjustments (consisting of only normal recurring accruals and elimination of intercompany balances and transactions) necessary to present fairly the financial position of Bed Bath & Beyond Inc. and subsidiaries (the “Company”) as of December 1, 2007 and March 3, 2007 and the results of its operations for the three and nine months ended December 1, 2007 and November 25, 2006, respectively, and its cash flows for the nine months ended December 1, 2007 and November 25, 2006, respectively.

 

The accompanying unaudited consolidated financial statements are presented in accordance with the requirements for Form 10-Q and consequently do not include all the disclosures normally required by U.S. generally accepted accounting principles. Reference should be made to Bed Bath & Beyond Inc.’s Annual Report on Form 10-K for the fiscal year ended March 3, 2007 (“2006 Form 10-K”) for additional disclosures, including a summary of the Company’s significant accounting policies, and to subsequently filed Forms 8-K.

 

The Company exhibits less seasonality than many other retail businesses, although sales levels are generally higher in August, November and December and generally lower in February and April.

 

2) Recent Accounting Pronouncements

 

In December 2007, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 141 (revised 2007), “Business Combinations.” SFAS No. 141R establishes principles and requirements for how the acquirer in a business combination recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquiree at the acquisition date fair value. SFAS No. 141R determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. SFAS No. 141R applies prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. Early adoption is not permitted.

 

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities-Including an amendment of FASB Statement No. 115.” SFAS No. 159 permits companies to choose to measure certain financial assets and liabilities at fair value (the “fair value option”). If the fair value option is elected, any upfront costs and fees related to the item must be recognized in earnings and cannot be deferred, e.g. debt issue costs. The fair value election is irrevocable and may generally be made on an instrument-by-instrument basis, even if a company has similar instruments that it elects not to fair value. At the adoption date, unrealized gains and losses on existing items for which fair value has been elected are reported as a cumulative adjustment to beginning retained earnings. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The Company is currently assessing the impact of SFAS No. 159 on its consolidated financial statements.

 

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements.” SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS No. 157 applies under other accounting pronouncements that require or permit fair value measurements and accordingly, does not require any new fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company does not believe the adoption of SFAS No. 157 will have a material impact on its consolidated financial statements.

 

3) Cash and Cash Equivalents

 

Included in cash and cash equivalents are credit and debit card receivables from banks, which typically settle within 5 business days, of $87.8 million and $44.3 million as of December 1, 2007 and March 3, 2007, respectively.

 

4) Property and Equipment

 

As of December 1, 2007 and March 3, 2007, $836.8 million and $720.6 million, respectively, of accumulated depreciation and amortization is included in property and equipment, net.

 

6



 

5) Stock-Based Compensation

 

The Company records stock-based compensation under the provisions of SFAS No. 123 (revised 2004), “Share-Based Payment” (“SFAS No. 123R”) which requires companies to measure all employee stock-based compensation awards using a fair value method and record such expense in its consolidated financial statements. The Company adopted SFAS No. 123R on August 28, 2005 (the “date of adoption”) under the modified prospective application. Under this application, the Company records stock-based compensation expense for all awards granted on or after the date of adoption and for the portion of previously granted awards that remained unvested at the date of adoption. Currently, the Company’s stock-based compensation relates to restricted stock awards and stock options. The Company’s restricted stock awards are considered nonvested share awards as defined under SFAS No. 123R.

 

The Company recorded stock-based compensation expense of $10.7 million ($7.1 million after tax or $0.03 per diluted share) and $31.2 million ($20.3 million after tax or $0.07 per diluted share) for the three and nine months ended December 1, 2007, respectively. The Company recorded stock-based compensation expense of $18.8 million ($12.1 million after tax or $0.04 per diluted share) and $43.1 million ($27.4 million after tax or $0.10 per diluted share) for the three and nine months ended November 25, 2006, respectively. Included in stock-based compensation for the three and nine months ended November 25, 2006 is a year-to-date non-cash charge of approximately $7.2 million, which represents the total of the first, second and third quarter charges for fiscal 2006 related to the impact of revised measurement dates (and the correction of various other immaterial errors) as a result of recommendations made by a special committee of the Board of Directors and implemented by the Company. See “Review of Equity Grants and Procedures and Related Matters.” In addition, the amount of stock-based compensation cost capitalized for the nine months ended December 1, 2007 and November 25, 2006 was approximately $1.0 million and $1.3 million, respectively.

 

Incentive Compensation Plans

 

The Company currently grants awards under the Bed Bath & Beyond 2004 Incentive Compensation Plan (the “2004 Plan”). The 2004 Plan is a flexible compensation plan that enables the Company to offer incentive compensation through stock options, stock appreciation rights, restricted stock awards and performance awards, including cash awards.

 

Prior to fiscal 2004, the Company had adopted various stock option plans (the “Prior Plans”), all of which solely provided for the granting of stock options. Upon adoption of the 2004 Plan, the common stock available under the Prior Plans became available for issuance under the 2004 Plan. No further option grants may be made under the Prior Plans, although outstanding awards under the Prior Plans will continue to be in effect.

 

Under the 2004 Plan and the Prior Plans, an aggregate of 83.4 million shares of common stock were authorized for issuance. The Company generally issues new shares for stock option exercises and restricted stock awards. Under the 2004 Plan, grants are determined by the Compensation Committee for those awards granted to executive officers and other key executives and by an appropriate committee for all other awards granted.

 

As of December 1, 2007, unrecognized compensation expense related to the unvested portion of the Company’s stock options and restricted stock awards, based on the Company’s historical treatment of options and awards as having been granted at fair market value, was $56.0 million and $83.0 million, respectively, which is expected to be recognized over a weighted average period of 2.9 years and 5.0 years, respectively.

 

Stock Options

 

The Company historically has treated its stock options as having been granted at fair market value on the date of grant (however, see “Review of Equity Grants and Procedures and Related Matters” for a discussion of a special committee review of equity grant matters which resulted in, among other things, the use of revised measurement dates for certain grants). The option grants generally become exercisable in five equal annual installments beginning one to three years from the date of grant. Option grants for stock options issued prior to May 10, 2004 expire ten years after the date of grant. Option grants for stock options issued since May 10, 2004 expire eight years after the date of grant. All option grants are non-qualified.

 

The fair value of the stock options granted was estimated on the date of the grant using a Black-Scholes option-pricing model that uses the assumptions noted in the following table. No options were granted during the third quarter of fiscal 2007.

 

7



 

 

 

Nine Months Ended

 

Black-Scholes Valuation Assumptions (1)

 

December 1,
2007

 

November 25,
2006

 

 

 

 

 

 

 

Weighted Average Expected Life (in years) (2)

 

6.43

 

6.33

 

Weighted Average Expected Volatility (3)

 

25.00

%

25.00

%

Weighted Average Risk Free Interest Rates (4)

 

4.58

%

4.95

%

Expected Dividend Yield

 

 

 

 


(1) Forfeitures are estimated based on historical experience.

(2) The expected life of stock options is estimated based on historical experience.

(3) The expected volatility is estimated based on implied volatility.

(4) Based on the U.S. Treasury constant maturity interest rate whose term is consistent with the expected life of the stock options.

 

Changes in the Company’s stock options for the nine months ended December 1, 2007 were as follows:

 

(Shares in thousands)

 

Number of Stock Options

 

Weighted Average
Exercise Price

 

Options outstanding, beginning of period

 

19,836

 

$

29.99

 

Granted

 

550

 

41.12

 

Exercised

 

(928

)

16.97

 

Forfeited or expired

 

(425

)

37.06

 

Options outstanding, end of period

 

19,033

 

$

30.79

 

Options exercisable, end of period

 

12,737

 

$

27.64

 

 

The weighted average fair value for the stock options granted through the first nine months of fiscal 2007 and fiscal 2006 was $15.07 and $14.24, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options outstanding as of December 1, 2007 was 4.1 years and $88.4 million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value for options exercisable as of December 1, 2007 was 3.6 years and $87.0 million, respectively. The total intrinsic value for stock options exercised during the first nine months of fiscal 2007 and fiscal 2006 was $18.8 million and $30.1 million, respectively.

 

Net cash proceeds from the exercise of stock options were $15.7 million and $23.7 million and the associated income tax benefits were $5.5 million and $10.4 million for the first nine months of fiscal 2007 and 2006, respectively.

 

Restricted Stock

 

The Company historically has treated its restricted stock awards as having been issued and measured at fair market value on the date of grant (however, see “Review of Equity Grants and Procedures and Related Matters” for a discussion of a special committee review of equity grant matters which resulted in, among other things, the use of revised measurement dates for certain grants). The restricted stock awards generally become exercisable in five equal annual installments beginning one to three years from the date of grant.

 

Vesting of restricted stock awarded to all executive officers and certain of the Company’s other executives is dependent on the Company’s achievement of a performance-based test for the fiscal year of grant, and assuming achievement of the performance-based test, time vesting, subject, in general, to the executive remaining in the Company’s employ on specified vesting dates. The Company recognizes compensation expense related to these awards based on the assumption that the performance-based test will be achieved. Vesting of restricted stock awarded to the Company’s other employees is based solely on time vesting.

 

8



 

Changes in the Company’s restricted stock for the nine months ended December 1, 2007 were as follows:

 

 

 

Number of Restricted

 

Weighted Average Grant-

 

(Shares in thousands)

 

Shares

 

Date Fair Value

 

Unvested restricted stock, beginning of period

 

1,931

 

$

37.25

 

Granted

 

1,115

 

39.83

 

Vested

 

(167

)

37.67

 

Forfeited

 

(126

)

37.91

 

Unvested restricted stock, end of period

 

2,753

 

$

38.24

 

 

Review of Equity Grants and Procedures and Related Matters

 

As described in a Form 8-K dated October 10, 2006, in June 2006, the Company’s Board of Directors appointed a special committee of independent directors to carry out a review with respect to the setting of exercise prices for employee stock options and related matters. The review identified various deficiencies in the process of granting and documenting stock options and restricted shares, as a result of which the measurement dates for various grants were revised. As a consequence, as described in the Company’s 2006 Form 10-K, the Company (i) recorded an adjustment for unrecorded expense over the affected period (fiscal year 1993 through 2005) of $61.8 million, and pursuant to Staff Accounting Bulletin (“SAB”) No. 108, “Considering the Effects of Prior Year Misstatements in Current Year Financial Statements,” decreased beginning retained earnings for fiscal 2006 by such amount, and (ii) recorded $8.2 million of expense for fiscal 2006. As described in a Form 8-K dated December 28, 2006 and the Company’s 2006 Form 10-K, the Company’s Board of Directors also approved during fiscal 2006 a remediation program intended to protect over 1,600 employees from certain potential adverse tax consequences arising under Section 409A of the Internal Revenue Code. No executive officers received any payments under such remediation program. The Company continues to cooperate with the inquiry of the SEC regarding the Company’s stock option grant practices.

 

The United States Attorney’s Office for the District of New Jersey has concluded its inquiry with respect to matters arising out of and related to the Company’s historical stock option grants and procedures and related matters and has indicated it will take no further action related to this matter.

 

6) Income Taxes

 

The Company adopted FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109” (“FIN 48”) on March 4, 2007. FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, the Company may recognize the tax benefit from uncertain tax positions only if it is at least more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon settlement with the taxing authorities. FIN 48 also provided guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

 

Upon adoption of FIN 48, the Company recognized a $13.1 million increase to retained earnings to reflect the change to its liability for unrecognized tax benefits as required. The Company also recorded additional unrecognized tax benefits, and corresponding higher deferred tax assets, of $35.6 million as a result of the adoption. At March 4, 2007 the total amount of gross unrecognized tax benefits was $163.3 million, of which $119.9 million would impact the Company’s effective tax rate. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. As of March 4, 2007, the liability for gross unrecognized tax benefits included approximately $27.5 million of interest.

 

As of December 1, 2007, the Company operated in 49 states, the District of Columbia and Puerto Rico and files income tax returns in the United States and various state and local jurisdictions. The Company is currently under examination by the Internal Revenue Service for tax years 2001 through 2005. The Company is also open to examination for state and local jurisdictions with varying statutes of limitations, generally ranging from three to five years.

 

The Company anticipates that any adjustments to unrecognized tax benefits which will impact income tax expense, due to the settlement of audits and the expiration of statutes of limitations, will not exceed $2 million in the next twelve months. However, actual results could differ from those currently anticipated.

 

9



 

During the three and nine months ended December 1, 2007, the Company paid certain liabilities of $23.2 million and $23.7 million, respectively, which did not have an impact on the consolidated statement of income as they were accrued for as unrecognized tax benefits. Also, during the three and nine months ended December 1, 2007, the Company effectively settled certain tax matters related to ongoing examinations which resulted in a reduction of income taxes payable of $39.5 million, partially offset by a reduction of deferred tax assets of $29.7 million. In addition, for the three and nine months ended December 1, 2007, reserves for tax uncertainties totaling approximately $2.4 million and $7.0 million, respectively, and interest totaling approximately $1.3 million and $5.8 million, respectively, were provided by the Company. As of December 1, 2007, the Company has recorded approximately $23.1 million and $86.4 million of unrecognized tax benefits in current and non-current income taxes payable, respectively, on the consolidated balance sheet.

 

7) Shareholders’ Equity

 

The Company’s Board of Directors has authorized repurchases of shares of its common stock in the amounts of $1.0 billion, $1.0 billion, $200 million, $400 million and $350 million in September 2007, December 2006, January 2006, October 2005 and December 2004, respectively.  The aggregate total of authorized repurchases of shares of common stock under the above share repurchase programs is approximately $3.0 billion. The Company was authorized to make repurchases from time to time in the open market or through other parameters approved by the Board of Directors pursuant to existing rules and regulations. The Company also purchases shares of its common stock to cover employee related taxes withheld on vested restricted shares. In the first nine months of fiscal 2007, the Company repurchased approximately 17.0 million shares of its common stock for an aggregate price of approximately $632 million, bringing the aggregate total of common stock repurchased to approximately 49.7 million shares for an aggregate price of approximately $1.9 billion since the initial authorization in December 2004.

 

8) Earnings Per Share

 

The Company presents earnings per share on a basic and diluted basis. Basic earnings per share has been computed by dividing net earnings by the weighted average number of shares outstanding. Diluted earnings per share has been computed by dividing net earnings by the weighted average number of shares outstanding including the dilutive effect of stock-based awards as calculated under the treasury stock method.

 

Stock-based awards for the three and nine months ended December 1, 2007 of approximately 11.4 million and 10.0 million shares, respectively, and for the three and nine months ended November 25, 2006 of approximately 8.3 million and 9.1 million shares, respectively, were excluded from the computation of diluted earnings per share as the effect would be anti-dilutive.

 

9) Lines of Credit

 

At December 1, 2007, the Company maintained two uncommitted lines of credit of $100 million and $75 million, with expiration dates of September 3, 2008 and February 28, 2008, respectively. These uncommitted lines of credit are currently, and are expected to be, used for letters of credit in the ordinary course of business. As of December 1, 2007, the Company did not have any direct borrowings under the uncommitted lines of credit. Although no assurances can be provided, the Company intends to renew both uncommitted lines of credit before the respective expiration dates.

 

10) Supplemental Cash Flow Information

 

The Company paid income taxes of $271.4 million and $296.3 million in the first nine months of fiscal 2007 and 2006, respectively.

 

The Company recorded an accrual for capital expenditures of $38.8 million and $47.9 million as of December 1, 2007 and November 25, 2006, respectively.

 

11) Acquisition

 

On March 22, 2007, the Company completed and announced the acquisition of buybuy BABY, a privately held retailer of infant and toddler merchandise, for approximately $67 million (net of cash acquired) and repayment of debt of approximately $19 million. Based in Garden City, New York, buybuy BABY operates a total of 8 stores in Maryland, New Jersey, New York and Virginia. The stores range in size from approximately 28,000 to 60,000 square feet and offer a broad assortment of premier infant and toddler merchandise in categories including furniture, car seats, strollers, feeding, bedding, bath, health

 

10



 

and safety essentials, toys, learning and development products, clothing and a unique selection of seasonal and holiday products.

 

buybuy BABY was founded in 1996 by Richard and Jeffrey Feinstein, both of whom were previously employed by the Company, and are the sons of Leonard Feinstein, one of the Company’s Co-Chairmen. The acquisition was approved by a special committee of independent members of the Board of Directors of the Company. The special committee retained Merrill Lynch & Co. to serve as its independent financial advisor and render a fairness opinion in connection with the transaction, as well as Chadbourne & Parke LLP to serve as independent legal counsel to oversee the acquisition negotiations. The aforementioned repayment of approximately $19 million of debt results in the retirement of all indebtedness of buybuy BABY, which debt was held by Richard and Jeffrey Feinstein (approximately $16 million) and Leonard Feinstein (approximately $3 million). The Company’s Co-Chairmen, Leonard Feinstein and Warren Eisenberg, recused themselves from deliberations relating to the transaction.

 

The results of buybuy BABY’s operations have been included in the consolidated financial statements since the date of acquisition.

 

11



 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

Bed Bath & Beyond Inc. and subsidiaries (the “Company”) is a chain of retail stores, operating under the names Bed Bath & Beyond (“BBB”), Christmas Tree Shops (“CTS”), Harmon and Harmon Face Values (“Harmon”) and buybuy BABY (See “Acquisition,” Note 11). The Company sells a wide assortment of merchandise principally including domestics merchandise and home furnishings as well as food, giftware, health and beauty care items and infant and toddler merchandise. The Company’s objective is to be a customer’s first choice for products and services in the categories offered, in the markets in which the Company operates.

 

The Company’s strategy is to achieve this objective through excellent customer service, an extensive breadth and depth of assortment, everyday low prices, introduction of new merchandising offerings and development of its infrastructure.

 

Operating in the highly competitive retail industry, the Company, along with other retail companies, is influenced by a number of factors, including but not limited to, consumer preferences and spending habits, general economic conditions, unusual weather patterns, competition from existing and potential competitors and the ability to find suitable locations at acceptable occupancy costs to support the Company’s expansion program. During the three and nine months ended December 1, 2007, the Company faced a challenging retailing environment related to the home.

 

As discussed in more detail below, the following represents an overview of the Company’s financial performance for the periods indicated:

 

·      For the three and nine months ended December 1, 2007, the Company’s net sales were $1.795 billion and $5.116 billion, respectively, and increased by 10.8% and 10.7%, respectively, as compared to the three and nine months ended November 25, 2006.

 

·      Comparable store sales for the fiscal third quarter of 2007 increased by approximately 0.8%, as compared with an increase of approximately 4.6%, for the corresponding period last year. Comparable store sales for the fiscal nine months of 2007 increased by approximately 1.5%, as compared with an increase of approximately 4.8%, for the corresponding period last year.

 

A store is considered a comparable store when it has been open for twelve full months following its grand opening period (typically four to six weeks). Stores relocated or expanded are excluded from comparable store sales if the change in square footage would cause meaningful disparity in sales over the prior period. In the case of a store to be closed, such store’s sales are not considered comparable once the store closing process has commenced.

 

·      Gross profit for the three months ended December 1, 2007 was $747.9 million or 41.7% of net sales compared with $704.1 million or 43.5% of net sales for the three months ended November 25, 2006. Gross profit for the nine months ended December 1, 2007 was $2.126 billion or 41.6% of net sales compared with $1.972 billion or 42.7% of net sales for the nine months ended November 25, 2006.

 

·      The effective tax rate was 33.6% and 35.0% for the three and nine months ended December 1, 2007, respectively, and 35.8% and 36.3% for the three and nine months ended November 25, 2006, respectively.

 

·      For the three and nine months ended December 1, 2007, the Company’s net earnings per diluted share increased to $0.52 (or $138.2 million) and $1.44 (or $389.9 million), respectively, as compared to $0.50 (or $142.4 million) and $1.36 (or $388.4 million), respectively, for the corresponding periods last year. The increases in net earnings per diluted share include the impact of the Company’s repurchases of its common stock.

 

Results of Operations

 

Net Sales

 

Net sales for the three months ended December 1, 2007 were approximately $1.795 billion, an increase of $175.5 million or approximately 10.8% over net sales of approximately $1.619 billion for the three months ended November 25, 2006. For the three months ended December 1, 2007, approximately 50% of the increase in net sales was attributable to an increase in the Company’s new store sales, with the remainder of the increase primarily attributable to a one week calendar shift in the current year’s quarter

 

12



 

end, the acquisition of buybuy BABY (acquired on March 22, 2007) and the increase in comparable store sales.

 

The increase in comparable store sales for the fiscal third quarter of 2007 was approximately 0.8%, as compared with an increase of approximately 4.6% for the corresponding period last year. The comparable store sales calculation for the three months ended December 1, 2007 compares the thirteen weeks in the third quarter of fiscal 2007 to the same calendar thirteen weeks in the prior year, so that the week after Thanksgiving in fiscal 2007 is compared to the week after Thanksgiving in fiscal 2006. The Company believes the smaller increase in the comparable store sales percentage versus the same period last year was primarily due to the challenging retailing environment related to the home.  The overall comparable store sales increase was particularly impacted by lower comparable store sales in those areas of the Country significantly affected by housing market issues, notably Arizona, California, Florida and Nevada.

 

For the three months ended December 1, 2007, sales of domestics merchandise and home furnishings for the Company accounted for approximately 45% and 55% of net sales, respectively. For the three months ended November 25, 2006, sales of domestics merchandise and home furnishings for the Company accounted for approximately 47% and 53% of net sales, respectively.

 

For the nine months ended December 1, 2007, net sales were approximately $5.116 billion, an increase of $493.3 million or approximately 10.7% over net sales of approximately $4.622 billion for the nine months ended November 25, 2006. For the nine months ended December 1, 2007, approximately 55% of the increase in net sales was attributable to an increase in the Company’s new store sales, with the remainder of the increase primarily attributable to the acquisition of buybuy BABY, the increase in comparable store sales and a one week calendar shift during the current year.

 

Comparable store sales for the fiscal nine months of 2007 increased by approximately 1.5%, as compared with an increase of approximately 4.8% for the corresponding period last year. The comparable store sales calculation for the nine months ended December 1, 2007 compares the thirty-nine weeks in the nine months of fiscal 2007 to the same calendar thirty-nine weeks in the prior year. The Company believes the smaller increase in the comparable store sales percentage versus the same period last year was primarily due to the challenging retailing environment related to the home and the results of a few key markets most affected by certain macroeconomic factors related to the home.

 

For the nine months ended December 1, 2007, sales of domestics merchandise and home furnishings for the Company accounted for approximately 45% and 55% of net sales, respectively.  For the nine months ended November 25, 2006, sales of domestics merchandise and home furnishings for the Company accounted for approximately 47% and 53% of net sales, respectively.

 

Gross Profit

 

Gross profit for the three months ended December 1, 2007 was $747.9 million or 41.7% of net sales compared with $704.1 million or 43.5% of net sales for the three months ended November 25, 2006. Gross profit for the nine months ended December 1, 2007 was $2.126 billion or 41.6% of net sales compared with $1.972 billion or 42.7% of net sales for the nine months ended November 25, 2006. The decreases in gross profit as a percentage of net sales for the three and nine months ended December 1, 2007 were attributable to a number of factors, including an increase in coupon redemptions associated with a heightened promotional environment, an increase in inventory acquisition costs and a shift in the mix of merchandise sold, as the Company experienced a higher percentage of sales of home furnishings.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses (“SG&A”) for the three months ended December 1, 2007 was $544.7 million or 30.4% of net sales compared to $492.9 million or 30.4% of net sales for the three months ended November 25, 2006. SG&A as a percentage of net sales was relatively flat for the three months ended December 1, 2007 compared to November 25, 2006 primarily due to a relative decrease in payroll and payroll-related items (due to a non-recurring $7.2 million charge in the fiscal third quarter of 2006 related to the review of stock option grants and procedures), offset by a relative increase in advertising expense for the current quarter as a result of increased distribution of advertising pieces in response to a heightened promotional environment.

 

SG&A for the nine months ended December 1, 2007 was $1.548 billion or 30.3% of net sales compared to $1.393 billion, or 30.1% of net sales for the nine months ended November 25, 2006. SG&A as a percentage of net sales increased for the nine months ended December 1, 2007 compared to November 25, 2006 due to a relative increase in advertising expense as a result

 

13



 

of increased distribution of advertising pieces in response to a heightened promotional environment partially offset by a relative decrease in payroll and payroll-related items (including a non-recurring $7.2 million charge in the fiscal third quarter of 2006 related to the review of stock option grants and procedures).

 

Operating Profit

 

Operating profit for the three months ended December 1, 2007 was $203.2 million, or 11.3% of net sales, compared to $211.1 million, or 13.0% of net sales, during the comparable period in 2006. For the nine months ended December 1, 2007, operating profit was $578.6 million, or 11.3% of net sales, compared to $579.5 million, or 12.5% of net sales, during the comparable period in 2006. The decreases in operating profit as a percentage of net sales for the three and nine month periods ended December 1, 2007 were primarily a result of the deleverage in the gross margin.

 

Interest Income

 

Interest income was $5.0 million and $21.6 million for the fiscal three and nine months ended December 1, 2007, respectively, compared to $10.6 million and $30.2 million for the corresponding periods last year. Interest income decreased primarily as a result of lower cash balances principally due to increased share repurchases during the current year.

 

Income Taxes

 

The effective tax rate was 33.6% and 35.0% for the three and nine months ended December 1, 2007, respectively, and 35.8% and 36.3% for the three and nine months ended November 25, 2006, respectively. The tax rate for the three months ended December 1, 2007 included an approximate $8.0 million benefit principally due to the effective settlement in the quarter of certain discrete tax items from ongoing examinations. The tax rate for the nine months ended December 1, 2007 included an approximate $17.1 million benefit primarily due to the effective settlement of certain discrete tax items from ongoing examinations, the recognition of favorable discrete state tax items and from changing the blended state tax rate of deferred income taxes.

 

The Company expects that FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes – an Interpretation of FASB Statement No. 109” (“FIN 48”) may, over time, create more volatility in the effective tax rate from quarter to quarter because the Company is required each quarter to determine whether new information changes the assessment of both the probability that a tax position will effectively be sustained and the appropriateness of the amount of recognized benefit.

 

Net Earnings

 

As a result of the factors described above, net earnings were $138.2 million for the fiscal third quarter of 2007 and $389.9 million for the fiscal nine months of 2007, compared with $142.4 million and $388.4 million for the corresponding periods in 2006, respectively.

 

Expansion Program

 

The Company is engaged in an ongoing expansion program involving the opening of new stores in both new and existing markets and the expansion or relocation of existing stores. As a result of this program, the Company operated 859 BBB stores, 39 CTS stores, 40 Harmon stores and 8 buybuy BABY stores (acquired as of March 22, 2007) at the end of the fiscal third quarter of 2007, compared with 795 BBB stores, 35 CTS stores and 38 Harmon stores at the end of the corresponding quarter last year. At December 1, 2007, Company-wide total store square footage was approximately 29.5 million square feet.

 

The Company opened 28 BBB stores, 3 CTS stores and 1 Harmon store during the third quarter of fiscal 2007. Including the 44 BBB stores opened in the fiscal nine months, the Company plans to open approximately 70 BBB stores (including its first store in Canada, which opened on December 6, 2007) in fiscal 2007; however, it is possible that approximately 3 to 5 of these openings may occur subsequent to year-end in March 2008. Additionally, including the 5 CTS stores opened in the fiscal nine months, the Company plans to open 6 to 7 CTS stores and 1 buybuy BABY store in fiscal 2007. The continued growth of the Company is dependent, in large part, upon the Company’s ability to execute its expansion program successfully.

 

Liquidity and Capital Resources

 

The Company has been able to finance its operations, including its expansion program, through internally generated funds. Net cash provided by operating activities for the nine months ended December 1, 2007 was $239.9 million as compared with $217.7 million in the corresponding period of fiscal 2006. The increase in net cash provided by operating activities in 2007 compared to 2006 was primarily the result of an increase in net earnings, as adjusted for non-cash expenses, primarily depreciation. There were no significant changes in the net components of working capital.

 

14



 

Inventory per square foot was $60.91 as of December 1, 2007 and $60.06 as of November 25, 2006. The Company continues to focus on optimizing inventory productivity while maintaining appropriate in-store merchandise levels to support sales growth.

 

Net cash provided by investing activities for the nine months ended December 1, 2007 was $349.0 million as compared with net cash used of $187.7 million in the corresponding period of fiscal 2006. The increase in net cash provided by investing activities was primarily attributable to an increase in the redemptions of investment securities, net of purchases, that was partially offset by an increase in capital expenditures and the payment for the acquisition of buybuy BABY.

 

Net cash used in financing activities for the nine months ended December 1, 2007 was $611.8 million as compared with $22.7 million of net cash provided by financing activities in the corresponding period of 2006. The net cash used in financing activities in 2007 was primarily attributable to common stock repurchases of $631.7 million.

 

Seasonality

 

The Company exhibits less seasonality than many other retail businesses, although sales levels are generally higher in August, November and December and generally lower in February and April.

 

Review of Equity Grants and Procedures and Related Matters

 

As described in a Form 8-K dated October 10, 2006, in June 2006, the Company’s Board of Directors appointed a special committee of independent directors to carry out a review with respect to the setting of exercise prices for employee stock options and related matters. The review identified various deficiencies in the process of granting and documenting stock options and restricted shares, as a result of which the measurement dates for various grants were revised. As a consequence, as described in the Company’s Annual Report on Form 10-K for the fiscal year ended March 3, 2007 (“2006 Form 10-K”), the Company (i) recorded an adjustment for unrecorded expense over the affected period (fiscal year 1993 through 2005) of $61.8 million, and pursuant to Staff Accounting Bulletin (“SAB”) No. 108, “Considering the Effects of Prior Year Misstatements in Current Year Financial Statements,” decreased beginning retained earnings for fiscal 2006 by such amount, and (ii) recorded $8.2 million of expense for fiscal 2006. As described in a Form 8-K dated December 28, 2006 and the Company’s 2006 Form 10-K, the Company’s Board of Directors also approved during fiscal 2006 a remediation program intended to protect over 1,600 employees from certain potential adverse tax consequences arising under Section 409A of the Internal Revenue Code. No executive officers received any payments under such remediation program. The Company continues to cooperate with the inquiry of the SEC regarding the Company’s stock option grant practices.

 

The United States Attorney’s Office for the District of New Jersey has concluded its inquiry with respect to matters arising out of and related to the Company’s historical stock option grants and procedures and related matters and has indicated it will take no further action related to this matter.

 

Recent Accounting Pronouncements

 

In December 2007, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 141 (revised 2007), “Business Combinations.” SFAS No. 141R establishes principles and requirements for how the acquirer in a business combination recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquiree at the acquisition date fair value. SFAS No. 141R determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. SFAS No. 141R applies prospectively to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after December 15, 2008. Early adoption is not permitted.

 

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities-Including an amendment of FASB Statement No. 115.” SFAS No. 159 permits companies to choose to measure certain financial assets and liabilities at fair value (the “fair value option”). If the fair value option is elected, any upfront costs and fees related to the item must be recognized in earnings and cannot be deferred, e.g. debt issue costs. The fair value election is irrevocable and may generally be made on an instrument-by-instrument basis, even if a company has similar instruments that it elects not to fair value. At the adoption date, unrealized gains and losses on existing items for which fair value has been elected are reported as a cumulative adjustment to beginning retained earnings. SFAS No. 159 is effective for fiscal years

 

15



 

beginning after November 15, 2007. The Company is currently assessing the impact of SFAS No. 159 on its consolidated financial statements.

 

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements.” SFAS No. 157 defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. SFAS No. 157 applies under other accounting pronouncements that require or permit fair value measurements and accordingly, does not require any new fair value measurements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company does not believe the adoption of SFAS No. 157 will have a material impact on its consolidated financial statements.

 

Critical Accounting Policies

 

See “Critical Accounting Policies” under Item 7 of the Company’s Fiscal 2006 Annual Report on Form 10-K, filed with the Securities and Exchange Commission on May 2, 2007 and incorporated by reference herein. There were no changes to the Company’s critical accounting policies except as follows.

 

Inventory Valuation:  Merchandise inventories continue to be stated at the lower of cost or market. Inventory costs for buybuy BABY, acquired in March 2007, are calculated using the first-in, first-out cost method.

 

Income Taxes:  During the first quarter of fiscal 2007, the Company adopted FIN 48. Under FIN 48, the Company recognizes the tax benefit from an uncertain tax position only if it is at least more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon settlement with the taxing authorities.

 

The Company expects that FIN 48 may, over time, create more volatility in the effective tax rate from quarter to quarter because the Company is required each quarter to determine whether new information changes the assessment of both the probability that a tax position will effectively be sustained and the appropriateness of the amount of recognized benefit.

 

Forward-Looking Statements

 

This Form 10-Q may contain forward-looking statements. Many of these forward-looking statements can be identified by use of words such as may, will, expect, anticipate, estimate, assume, continue, project, plan, and similar words and phrases. The Company’s actual results and future financial condition may differ materially from those expressed in any such forward-looking statements as a result of many factors that may be outside the Company’s control. Such factors include, without limitation: changes in the retailing environment and consumer preferences and spending habits; demographics and other macroeconomic factors that may impact the level of spending for the types of merchandise sold by the Company; general economic conditions; unusual weather patterns; competition from existing and potential competitors; competition from other channels of distribution; pricing pressures; the cost of labor, merchandise and other costs and expenses; the ability to find suitable locations at acceptable occupancy costs to support the Company’s expansion program; and matters arising out of or related to the Company’s stock option grants and procedures and related matters, including the outcome of the informal inquiry commenced by the SEC, the possibility that the SEC may not agree with all of the special committee’s findings and recommendations and may require additional or different remediation, any other proceedings which may be brought against the Company by the SEC or other governmental agencies, any tax implications relating to the Company’s stock option grants, the outcome of the shareholder derivative actions filed against certain of the Company’s officers and directors, and the possibility of other private litigation relating to such stock option grants and related matters. The Company does not undertake any obligation to update its forward-looking statements.

 

Available Information

 

The Company makes available as soon as reasonably practicable after filing with the SEC, free of charge, through its website, www.bedbathandbeyond.com, the Company’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, electronically filed or furnished pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

16



 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

The Company’s exposure to market risk for changes in interest rates relates primarily to the Company’s investment securities. The Company’s market risks at December 1, 2007 are similar to those disclosed in Item 7a of the Company’s Form 10-K for the year ended March 3, 2007.

 

Item 4. Controls and Procedures

 

(a)     Disclosure Controls and Procedures

 

The Company’s Principal Executive Officer and Principal Financial Officer have reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 240.13a-15(e) and 15d-15(e)) as of December 1, 2007 (the end of the period covered by this quarterly report on Form 10-Q). Based on that evaluation, the Principal Executive Officer and the Principal Financial Officer have concluded that the Company’s current disclosure controls and procedures are effective to ensure that information required to be disclosed by our management in the reports that it files or submits under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, to allow timely decisions regarding required disclosure.

 

(b)     Changes in Internal Control over Financial Reporting

 

There were no changes in the Company’s internal controls over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Two purported derivative actions were filed in New Jersey Superior Court naming several officers and the directors of the Company as defendants and making allegations concerning alleged historical options backdating practices at the Company. Those two actions were consolidated, and a consolidated complaint was filed in late November 2006. Subsequently, five additional purported derivative actions were filed, all concerning the same subject matter. Wandel v. Eisenberg, et al., was filed on October 19, 2006 in the Supreme Court of the State of New York, County of New York; Jamieson v. Eisenberg, et al. was filed on January 5, 2007 in the New Jersey Superior Court; and three cases were filed in the United States District Court for the District of New Jersey, Snowball Capital Appreciation Fund v. Eisenberg, et al.; Crowley v. Temares, et al.; and Cummings v. Temares, et al. on October 17, 2006, October 24, 2006 and October 25, 2006, respectively. The Snowball Capital Appreciation Fund v. Eisenberg, et al. and Jamieson v. Eisenberg, et al. cases have been voluntarily dismissed. The Crowley v. Temares, et al. and Cummings v. Temares, et al. cases have been consolidated (the “Consolidated Federal Derivative Case”). During the fiscal first quarter of 2007, the Wandel v. Eisenberg, et al. case was dismissed by the Supreme Court of the State of New York, but the plaintiff in the case has filed a notice of appeal. During the fiscal third quarter of 2007, the Consolidated Federal Derivative Case was dismissed by the United States District Court for the District of New Jersey. In each case, the Company is a nominal defendant against which no recovery is sought.

 

The Company is, in addition, party to various other legal proceedings arising in the ordinary course of business, which the Company does not believe to be material to the Company’s business or financial condition.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Form 10-Q, carefully consider the factors discussed under “Risk Factors” in the Company’s Form 10-K for the fiscal year ended March 3, 2007 as filed with the SEC, including conditions affecting the retail environment for the home, as well as matters arising out of or related to the Company’s stock option grants and procedures and related matters, including the outcome of the informal inquiry commenced by the SEC, the possibility that the SEC may not agree with all of the special committee’s findings and recommendations and may require additional or different remediation, any other proceedings which may be brought against the Company by the SEC or other governmental agencies, any tax implications relating to the Company’s stock option grants, the outcome of the shareholder derivative actions filed against certain of the Company’s officers and directors, and the possibility of other private litigation relating to such stock option grants and related matters. See “Management’s Discussion and Analysis of Financial Condition and Results of

 

17



 

Operations – Review of Equity Grants and Procedures and Related Matters” and “Legal Proceedings.”  These risks could materially adversely affect the Company’s business, financial condition and results of operations. These risks are not the only risks the Company faces. The Company’s operations could also be affected by additional factors that are not presently known to the Company or by factors that the Company currently considers immaterial to its business.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The Company’s purchases of its common stock during the third quarter of fiscal 2007 were as follows:

 

 

 

 

 

 

 

 

 

Approximate Dollar

 

 

 

 

 

 

 

Total Number of

 

Value of Shares

 

 

 

 

 

 

 

Shares Purchased as

 

that May Yet Be

 

 

 

 

 

 

 

Part of Publicly

 

Purchased Under

 

 

 

Total Number of

 

Average Price

 

Announced Plans

 

the Plans or

 

Period

 

Shares Purchased (1)

 

Paid per Share

 

or Programs (1)

 

Programs (1) (2)

 

September 2, 2007 - September 29, 2007

 

2,000

 

$

32.99

 

2,000

 

1,172,872,115

 

September 30, 2007 - October 27, 2007

 

425,000

 

$

34.55

 

425,000

 

1,158,196,084

 

October 28, 2007 - December 1, 2007

 

2,827,000

 

$

31.33

 

2,827,000

 

1,069,618,029

 

Total

 

3,254,000

 

$

31.75

 

3,254,000

 

1,069,618,029

 

 


(1) The Company’s Board of Directors has authorized repurchases of shares of its common stock in the amount of $1 billion, $1 billion, $200 million, $400 million and $350 million in September 2007, December 2006, January 2006, October 2005 and December 2004, respectively. The Company was authorized to make repurchases from time to time in the open market or through other parameters approved by the Board of Directors pursuant to existing rules and regulations. Shares purchased indicated in this table also include the withholding of a portion of restricted shares to cover taxes on vested restricted shares.

(2) Excludes brokerage commissions paid by the Company.

 

Item 6. Exhibits

 

The exhibits to this Report are listed in the Exhibit Index included elsewhere herein.

 

18



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

BED BATH & BEYOND INC.

 

 

(Registrant)

 

 

 

 

 

 

 

Date: January 10, 2008

By:

  /s/ Eugene A. Castagna

 

 

 

Eugene A. Castagna

 

 

Chief Financial Officer and

 

 

Treasurer

 



 

EXHIBIT INDEX

 

Exhibit No.

 

Exhibit

 

 

 

 

 

31.1

 

Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes - Oxley Act of 2002.

 

 

 

 

 

31.2

 

Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes - Oxley Act of 2002.

 

 

 

 

 

32

 

Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.